GMVDF Stock - G Medical Innovations Holdings Ltd
Unlock GoAI Insights for GMVDF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $4.42M | $4.96M | $4.90M | $5.53M | $3.06M |
| Gross Profit | $784,000 | $1.51M | $667,000 | $-223,000 | $-969,000 |
| Gross Margin | 17.7% | 30.4% | 13.6% | -4.0% | -31.6% |
| Operating Income | $-22,113,000 | $-10,968,000 | $-12,300,000 | $-12,779,000 | $-17,184,000 |
| Net Income | $-24,629,000 | $-14,758,000 | $-12,536,000 | $-15,509,000 | $-16,976,000 |
| Net Margin | -557.2% | -297.5% | -255.8% | -280.7% | -554.4% |
| EPS | $-34.17 | $-45.49 | $-59.67 | $-7.00 | $-8.75 |
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures ECG data continuously for up to 14 days. It develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was incorporated in 2014 and is headquartered in Rehovot, Israel.
Visit WebsiteEarnings History & Surprises
GMVDFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Jan 27, 2025 | — | — | — | — |
Q4 2024 | Nov 18, 2024 | — | — | — | — |
Q3 2024 | Aug 28, 2024 | — | — | — | — |
Q2 2024 | May 28, 2024 | $-0.06 | — | — | — |
Q1 2024 | Jan 11, 2024 | — | — | — | — |
Q4 2023 | Nov 28, 2023 | $-0.08 | — | — | — |
Q2 2023 | May 29, 2023 | — | — | — | — |
Q2 2023 | Apr 9, 2023 | — | — | — | — |
Q1 2023 | Mar 6, 2023 | $-0.15 | — | — | — |
Q4 2022 | Nov 18, 2022 | $-0.14 | — | — | — |
Q2 2022 | Apr 29, 2022 | $-0.39 | — | — | — |
Q3 2021 | Sep 15, 2021 | — | $-0.51 | — | — |
Q2 2021 | Apr 22, 2021 | — | — | — | — |
Q3 2020 | Sep 1, 2020 | — | — | — | — |
Latest News
Frequently Asked Questions about GMVDF
What is GMVDF's current stock price?
What is the analyst price target for GMVDF?
What sector is G Medical Innovations Holdings Ltd in?
What is GMVDF's market cap?
Does GMVDF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to GMVDF for comparison